Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetes Technology Consultants is a specialized professional services firm focused on the clinical, regulatory, and technical development of technologies for diabetes management. Led by Dr. David Klonoff, a prominent endocrinologist and leader in the field, the company provides expert guidance to medical device manufacturers and pharmaceutical companies on the design and execution of clinical trials. Their expertise covers a wide range of innovations, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery systems, and digital health platforms. The firm plays a critical role in helping clients navigate FDA regulatory pathways and establish industry standards for data interoperability and device safety. By bridging the gap between technological innovation and clinical application, Diabetes Technology Consultants facilitates the commercialization of advanced tools for the global diabetes community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetes Technology Consultants.